IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.48
−8.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.35x
- Price / sales
- -5743.91x
- Price / cash flow
- -10.36x
Enterprise value
- Enterprise value
- $90.9M
- EV / sales
- -2394.43x
- EV / EBITDA
- -2.81x
- EV / EBIT
- -2.49x
- Market cap
- $218.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026